Bevacizumab Monotherapy as Salvage Therapy for Advanced clear cell Renal Cell Carcinoma (ccRCC) Pretreated with Targeted Drugs

Bevacizumab has shown benefit in the first line setting in combination with interferon; however, data on use as monotherapy are limited. This retrospective analysis of 71 patients assesses the efficacy of bevacizumab monotherapy in patients who progressed on other targeted drugs. Bevacizumab monothe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Genitourin Cancer
Auteurs principaux: Lee, Chung-Han, Hötker, Andreas M., Voss, Martin H., Feldman, Darren R., Woo, Kaitlin M., Patil, Sujata, Coskey, Devyn T., Akin, Oguz, Hsieh, James J., Motzer, Robert J.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4965701/
https://ncbi.nlm.nih.gov/pubmed/26404107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2015.07.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires